Ivím Health
US$ 20.91
semaglutide immune system Spotlight on the Mechanism of Action of Frontiers | GLP-1 receptor agonist
Description
Sanjay R Vyas
Latest KOL Views on GLP-1 agonists To keep up with current and future GLP-1 agonists market trends, we incorporate Key physicians, Therapy Area Researchers, and other Industry Experts opinions working in the domain through primary research to fill in the data gaps and validate our secondary research
Rhodes, MD, an obesity medicine
Wegovy (semaglutide) Wegovy is a GLP-1 receptor agonist with semaglutide as an active ingredient
doi: 10.1136/gutjnl-2012-303839
& Xin, W
